LSX-Blog.png

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

Global capabilities for local growth

NDA's support of the Nordic biotech community

Read More

Surgify - Groundbreaking tissue selective bone cut...

Unique safety technology based on a clever innovation can save billions of ...

Read More

Vesalius Biocapital III Announced the Final Close ...

Following the announcement from Vesalius Biocapital we spoke to Marc Lohrma...

Read More

DIGIHEALTH LEADERS LAUNCHES WITH THE MISSION TO CO...

DigiHealth Leaders brings the industry together for strategy, education, pa...

Read More

40 Digital Health leaders to meet this year

This eBook showcases 40 ecosystem leaders in the digital health space that ...

Read More

30 DigiHealth Startups to meet this year

Welcome to our first eBook in a series featuring the most innovative and in...

Read More

50 Scandinavian biotech and medtech companies you ...

We've already released two bespoke eBooks focusing on Nordic startups and p...

Read More

Company creation and early-stage investing in life...

There is an abundance of promising scientific research that has the potenti...

Read More

SPC you later to drug-device combinations

On 25 October 2018 the Court of Justice of the European Union (CJEU) handed...

Read More

Investing in Early-Stage Innovation: Q&A with Sano...

How are established investors working to foster innovation in today’s biote...

Read More

New formulations of existing active substances are...

The Opinion of Advocate General Saugmandsgaard Øe in Abraxis Bioscience (Ca...

Read More

Addex prepares PD-LID programme for 2019 Phase 3 r...

Key findings: Switzerland-based Addex Therapeutics is preparing its lead ca...

Read More

Add Your Response